`cument
`L:22-cv-01391-
`ase
`Case i22-cv-01391-GBW Document4 Filed 10/24
`
`PacelD #: 78
`Page loli
`Page loti Pagelb
`
`AO 120 (Rev. 08/10
`
`TRADEMARK
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`
`TO:
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`
`filed in the U.S. District Court
`for the District of Delaware
`on the following
`(_] Trademarks or
`(W Patents.
`( [) the patent action involves 35 U.S.C. § 292.):
`
`ALCON INC. and ALCON LABORATORIES, INC.
`
`DEFENDANT
`
`AUROBINDO PHARMA LTD. and
`AUROBINDO PHARMA USA, INC.
`
`PATENT OR
`
`DATE INCLUDED
`
`In the above—entitled case, the following patent(s)/ trademark(s) have been included:
`INCLUDED BY
`
`L] Answer
`
`DATE OF PATENT
`
`(BY) DEPUTY CLERK
`
`L] Cross Bill
`
`L] Other Pleading
`
`] Amendment
`PATENT OR
`DATE OF PATENT
`TRADEMARKNO.
`OR TRADEMARK
`HOLDER OF PATENT OR TRADEMARK
`eees
`aes
`aes
`eees
`Be
`
`In the above—entitled case, the following decision has been rendered or judgementissued:
`DECISION/JUDGEMENT
`
`Copy 1—Uponinitiation of action, mail this copy to Director Copy 3—Upontermination of action, mail this copy to Director
`Copy 2—Uponfiling document adding patent(s), mail this copy to Director Copy 4—Casefile copy
`
`